Table 4 miR-320a expression does not vary in subgroups defined by categorical variables associated with Arrhythmogenic CardioMyopathy (ACM) severity.

From: MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy

 

MAE+

MAE−

p

n

24

12

 

miR-320a

0.35 ± 0.03

0.42 ± 0.05

0.22

 

Severe ACM (imaging)

Mild ACM (imaging)

p

n

11

18

 

miR-320a

0.31 ± 0.04

0.37 ± 0.03

0.16

  1. MAE+, patients presenting with a history of Major Arrhythmic Events; MAE−, patients not presenting history of MAE; miR-320a, relative expression levels showed as mean fold change ± SEM (calculated with respect to HC). Severe/Mild ACM (imaging), patients presenting severe or mild ventricular impairment, respectively (defined as absence of ventricular dilation and/or bulging at cardiac echocardiography or magnetic resonance imaging). For each variable the p-value of the Fisher’s exact test is reported.
Back to article page